Diabetes Care during the COVID-19 era in the IDF North American and Caribbean (NAC) region
30 March, 2021, 16:00 CEST – 10:00 EDT
This webinar, organised by the International Diabetes Federation (IDF) and the Panamerican Health Organization (PAHO), provided an opportunity to learn about the impact that the COVID-19 pandemic has had on diabetes care in North America and the Caribbean.
Health professionals, institutional representatives and people with diabetes presented their different perspectives and discussed how to improve diabetes care in pandemic situations.
This webinar was followed live by 286 live attendees, and included the following speakers:
Dr Timotheus Dorh, Chair, IDF North America and Caribbean region
Dr Anselm Hennis, Director, PAHO/WHO Department on NCDs and Mental Health
Dr Takira Glasgow, physician and diabetologist (Saint Lucia)
Ms Lurline Less, Chair, Diabetes Association of Jamaica
Ms Betsy Rodríguez, nurse and diabetes educator (USA)
Ms Diana Estephanía Novelo Alzina, IDF Young Leader living with type 1 diabetes (Mexico)
Mr Michael Donohoe, IDF Blue Circle Voice living with type 2 diabetes (USA)
To mark the publication of the IDF-DAR Diabetes and Ramadan Practical Guidelines 2021, the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance are hosting a series of regional online workshops in February and March 2021. Registration and participation is free of charge.
February 13 - DAR Francophone - Programme (view recording below)
February 20 - DAR Africa - Programme(view recording below)
February 26 - DAR Middle-East and North Africa - Programme (view recording below)
February 27 - DAR Asia - Programme(view recording below)
February 27 - DAR North America and Caribbean - Programme(view recording below)
The workshops will address the content of the IDF-DAR Guidelines, developed by leading experts in the field of diabetes and Ramadan, and focus on management recommendations to optimise the care delivered to people with diabetes who plan to fast.
The IDF-DAR Ramadan Guidelines workshops are supported by an unconditional grant from Sanofi and Servier.
DAR Francophone (February 13, 2021)
DAR Africa (February 20, 2021)
DAR Middle-East and North Africa (February 26, 2021)
DAR Asia (February 27, 2021)
DAR North America and Caribbean (February 27, 2021)
El cuidado de la diabetes durante la pandemia de COVID-19 en la región de América Central y del Sur (SACA)
9 de febrero de 2021, 20:00 CET – 14:00 EST
Este webinario, co-organizado por la Federación Internacional de Diabetes (FID) y la Organización Panamericana de la Salud (OPS), proporcionó una oportunidad para conocer el impacto que la pandemia de COVID-19 ha tenido en el cuidado de la diabetes en América Central y del Sur.
Profesionales de la salud, representantes institucionales y personas con diabetes presentaron sus diferentes perspectivas y hablaron sobre cómo mejorar la atención en diabetes en situaciones de pandemia.
Este webinario fue seguido en directo por 582 personas, y contó con los siguientes oradores:
Dr Douglas Villarroel, Presidente de la región SACA de la FID 2020-2021
Lic Olivia Brathwaite, Consejera de ENT de la OPS
Dra Julieta Méndez, Encargada del Programa Nacional de Diabetes (Argentina)
Dr Ammar Ibrahim, Médico (República Dominicana)
Dr Mark Barone, Director de la Asociación de Diabetes Juvenil (Brasil)
Sra Mishell Ojeda, Enfermera (Ecuador)
Sra Ericka Padilla Abarca, Miembro de la red Blue Circle Voices de la FID con diabetes tipo 2 (Costa Rica)
Sra Estefanía Malassisi, Joven Lider de la FID con diabetes tipo 1 (Argentina)
Puede descargar el orden del día de este webinario y las biografías de los oradores aquí.
Se puede ver la grabación del webinario en YouTube:
Para las personas que no pudieron acceder en directo al webinario debido a la limitación de plazas, se realizará una retransmisión de la grabación en el perfil de Facebook de la FID el miércoles 10 de febrero a las 20:00 CET - 14:00 EST.
Diabetes has been increasing at an alarming rate since the start of the 21st century, driven by health determinants that are largely related to lifestyle changes and their consequences, such as obesity and a sedentary lifestyle. The impact of diabetes has overwhelmed many healthcare systems, particularly those in low and middle-income countries. Reversing the rapid rise in the number of cases and preventing the onset and evolution of diabetes complications should be a common goal.
This is essential to ensure that people who develop diabetes achieve their full life expectancy without compromising their quality of life, while also reducing the economic impact of the condition. A prerequisite to achieving this goal is the ability to measure the distribution of the disease (prevalence and incidence), its determinants (risk factors), and consequences (complications, mortality and health expenditure).
The IDF Guide for Diabetes Epidemiology Studies has been developed to create standardised epidemiological methods in diabetes studies. It will enable researchers to conduct high-quality studies that generate robust data, thereby providing the information needed to develop evidence-based strategies for improving care and strengthening healthcare systems.
Over 460 million people around the world are currently living with diabetes. Many, particularly in low and middle-income countries, do not have the means to access the medications and supplies they need to manage their condition to avoid complications.
People with diabetes need uninterrupted access to medicines and care. They need healthy food and a safe space to exercise. Caring for diabetes becomes even more difficult when disaster strikes and people are forced to flee. In these difficult circumstances, people with diabetes often struggle to manage their condition and are at increased risk of life-threatening complications.
Since 2009, the International Diabetes Federation has collaborated with the humanitarian organisation Direct Reliefto provide access to life-sustaining medication and monitoring to vulnerable populations. The supplies include insulin, needles & syringes, blood glucose meters & strips, and specialized diagnostic equipment.
Direct Relief is active in more than 80 countries, with a mission to improve the health and lives of people affected by poverty or emergencies – without regard to politics, religion, or ability to pay. Their assistance programmes are tailored to the particular circumstances and needs of the world's most vulnerable and at-risk populations and their relationships with prominent regional and global associations and agencies enable them to respond to crisis situations in the most timely and effective manner possible.
Direct Relief works closely with all three global insulin manufacturers and is currently the world’s largest provider of humanitarian insulin. Direct Relief’s facility has the refrigeration capacity to store specialty medicines (up to 300 pallets of cold- chain product) for distribution to over 100 countries around the world.
Temperature-sensitive medicines like insulin are shipped in specialised packaging that maintains a constant temperature range for up to 120 hours. To ensure and verify that temperature has been maintained throughout the transit process, temperature-data loggers are inserted into each package to record the internal temperature of the shipment, to be confirmed within range before the product is released for use by those who need them.
In 2019, IDF and Direct Relief began a pilot collaboration to encourage healthcare manufacturers to donate diabetes-related medications and supplies to help address gaps in diabetes care during times of emergency and or crisis situations. The collaboration has resulted in the donation and distribution of over 5 million tablets of oral diabetes medications, tens of thousands of vials of insulin, and diabetes-related supplies to numerous countries, including the Bahamas, Bolivia, Democratic Republic of Congo, Ethiopia, Kurdistan, Malawi, North Korea, Republic of Congo, Syria, Venezuela, and Zimbabwe.
IDF and Direct Relief are inviting healthcare companies that manufacture diabetes-related medicines, enabling technologies, and diagnostic products to support this programme with regular donations to assist countries and regions impacted by emergency and disaster situations. IDF will help identify and work with its members in those affected regions that need support to ensure an appropriate and rapid response.
For more information about the initiative and how to support it, please contact: